Recently, Goto Biopharm and Huahai Pharmaceutical hold exchange meetings to discuss and promote the construction of joint venture projects.
Goto Biopharm is a high-tech enterprise specializing in the R&D, production and sales of steroidal drug materials. The main products are starting materials and intermediates for steroidal drugs. The company is one of the largest suppliers in the field of steroidal drug starting materials in China.
Both Goto Biopharm and Huahai Pharmaceutical are optimistic about the development prospects of the steroid drug industry. Goto Biopharm has the advantages of technology, starting materials and large-scale production in the steroid drug industry. Huahai Pharmaceutical has strong quality management system, It has advantages in registeration and overseas sales networks. The two parties have given full play to their respective advantages and formally established a joint venture company on May 13 to develop the high-end steroid drug industry and achieve in-depth strategic cooperation between the two parties.
Huahai Pharmaceuticals stated that it will take the international market and industrial chain advantages of the intermediates, APIs, combined with the accumulated advantages of Goto Biopharm in the field of steroid technology, to help promote the joint venture in the high Competitiveness of steroid series APIs.